BRAF and melanoma: Phenformin is currently in a few clinical trials including a phase I clinical trial to determine optimal dosage for combined treatment with small molecule targeted therapies (Dabrafenib and Trametinib) for patients with BRAF mutated melanoma (NCT03026517).9